Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Staging of Intracranial Ependymoma in Children and Adults

1 Jun 2010

Abstract excerpt

PURPOSE: The biologic behavior of intracranial ependymoma is unpredictable on the basis of current staging approaches. We aimed at the identification of recurrent genetic aberrations in ependymoma and evaluated their prognostic significance to develop a molecular staging system that could complement current classification criteria. PATIENTS AND METHODS: As a screening cohort, we studied a cohort of 122 patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epilepsy research and treatment
Share to Genomic variations and chromosomal abnormalities
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20516456
DOI: 10.1200/jco.2009.27.3359

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Staging of Intracranial Ependymoma in Children and AdultsPMID 20516456Read ↗

Identification of Tumor-Specific Molecular Signatures in Intracranial Ependymoma and Association With Clinical CharacteristicsSemantic proximity Read ↗

Intracranial ependymomas: molecular insights and translation to treatmentSemantic proximity Read ↗

Molecular genetics of ependymomaSemantic proximity Read ↗

Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).Semantic proximity Read ↗

Pediatric Ependymoma: Biological PerspectivesSemantic proximity Read ↗

Put away your microscopes: the ependymoma molecular era has begunSemantic proximity Read ↗

A review of recently described genetic alterations in central nervous system tumors.Semantic proximity Read ↗

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumorsSemantic proximity Read ↗

Emerging Insights into the Ependymoma EpigenomeSemantic proximity Read ↗

Recent Advances in the Classification and Treatment of Ependymomas.Semantic proximity Read ↗

Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features – a retrospective analysis of the HIT ependymoma trial cohortSemantic proximity Read ↗

Molecular subtyping of ependymoma and prognostic impact of Ki-67Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.